Exposure to Anthracyclines During Childhood Causes Cardiac Injury
- 30 June 2006
- journal article
- review article
- Published by Elsevier in Seminars in Oncology
- Vol. 33, 8-14
- https://doi.org/10.1053/j.seminoncol.2006.04.019
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Wise up: Do not do it without protection!Pediatric Blood & Cancer, 2005
- Protecting against anthracycline‐induced myocardial damage: a review of the most promising strategiesBritish Journal of Haematology, 2005
- Cardiotoxicity of Cancer ChemotherapyPediatric Drugs, 2005
- Role and importance of biochemical markers in clinical cardiologyEuropean Heart Journal, 2004
- Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and CardiotoxicityPharmacological Reviews, 2004
- Enalapril to Prevent Cardiac Function Decline in Long-Term Survivors of Pediatric Cancer Exposed to AnthracyclinesJournal of Clinical Oncology, 2004
- Radiation-associated cardiovascular disease: manifestations and managementSeminars in Radiation Oncology, 2003
- Doxorubicin Administration by Continuous Infusion Is Not Cardioprotective: The Dana-Farber 91-01 Acute Lymphoblastic Leukemia ProtocolJournal of Clinical Oncology, 2002
- Improved outcome for children with acute lymphoblastic leukemia: results of Dana-Farber Consortium Protocol 91-01Blood, 2001
- Prevention of Heart FailureCardiology, 1999